We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Nanotechnology Approach Locates and Removes Dangerous Endometriosis Lesions

By HospiMedica International staff writers
Posted on 27 Apr 2022

Endometriosis is a common gynecological condition in women of childbearing age. More...

The endometrium is the innermost layer of the uterus, and endometriosis occurs when endometrium-like tissue forms lesions outside of the uterine cavity – usually involving the ovaries, the fallopian tubes and the tissue lining the pelvis. On rare occasions, endometrial tissue may spread beyond the pelvic region. There’s no cure for endometriosis, although surgical removal of the lesions can improve fertility. The downside, however, is that the lesions come back about half the time, and more than one-quarter of endometriosis surgery patients need three or more operations because it’s hard to find all of the diseased tissue that needs to be removed. Scientists have now developed a new nanotechnology approach for locating and removing the painful and dangerous lesions associated with endometriosis.

The research led by scientists at the Oregon State University (OSU, Corvallis, OR, USA) involves magnetic nanoparticles - tiny pieces of matter as small as one-billionth of a meter. An animal-model study showed that the iron oxide nanoparticles, injected intravenously, act as a contrast agent – they accumulate in the lesions, making them easier to see by advanced imaging such as MRI. And when exposed to an alternating magnetic field, a non-invasive procedure, the nanoparticles’ temperature soars to more than 120 degrees Fahrenheit, high enough for lesion removal via heat.

Magnetic hyperthermia had not previously been considered as a potential means of ablating endometriosis lesions because other magnetic nanoparticles have relatively low heating efficiency. The nanoparticles could only get hot enough after being directly injected into diseased tissue, which is not a realistic approach for endometriosis. The researchers overcame that problem by developing hexagonal-shaped nanoparticles that have more than six times the heating efficiency of conventional spherical nanoparticles when subjected to an alternating magnetic field.

Modifying the nanoparticles with a peptide - multiple amino acids linked in a chain – that targets a cellular receptor abundant in endometriosis cells enhanced their ability to accumulate in endometriosis lesions, the scientists said. Studies of mice with endometriotic tissue transplanted from macaques demonstrated the nanoparticles’ ability to eradicate the diseased cells following one session of magnetic hyperthermia.

“Endometriosis is a debilitating, systemic disease, and the need for an efficient, non-surgical method of removing the lesions is urgent,” said Oleh Taratula of the Oregon State University College of Pharmacy who led the research. “We invented targeted nanoparticles with extraordinary heating capabilities that enable the use of magnetic hyperthermia for the safe and efficient elimination of endometriosis lesions.”

Related Links:
Oregon State University 


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
Cardiograph Device
PageWriter TC35
Isolation Stretcher
IS 736
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.